Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SpaceIT Hydrogel System for Perirectal Spacing in Subjects With Low to Intermediate Risk Prostate Cancer Undergoing External Beam Radiotherapy (EBRT)

NCT06451614 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT06451614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06451614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SpaceIT Hydrogel System for Perirectal Spacing in Subjects With Low to Intermediate Risk Prostate Cancer Undergoing External Beam Radiotherapy (EBRT)
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 30, 2024
Completion date
March 31, 2028
Enrollment
230 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer